Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$24,099,414
-$19,586,112 QoQ
Shares Held
31,191
-44.9% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ING GROEP NV holds $89,261,587 across 9 Biotechnology names. REGN ranks #2 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,425 | $29,214,879 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
31,191 | $24,099,414 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
391,500 | $10,844,550 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
103,000 | $10,016,750 | |
| 5 | NKTR |
Nektar Therapeutics
|
100,000 | $7,195,000 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
28,214 | $5,333,856 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
122,100 | $1,150,182 | |
| 8 | INSM |
INSMED Inc
|
5,996 | $980,465 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,099,414 | 31,191 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $43,685,526 | 56,597 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $61,218,270 | 108,877 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $24,217,200 | 46,128 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $13,528,760 | 21,331 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $20,718,118 | 29,085 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $22,876,033 | 21,761 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $5,318,211 | 5,060 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,282,714 | 27,307 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $24,865,268 | 28,311 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $29,457,853 | 35,795 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $23,527,155 | 32,743 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $26,978,712 | 32,834 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $19,973,007 | 27,683 | Shares | Defined | 2023-02-13 | |
| 2022-06-30 | $15,742,383 | 26,631 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $37,806,173 | 54,131 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,127,620 | 49,290 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,459,691 | 10,674 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $5,833,950 | 10,445 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $3,360,030 | 6,955 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,295,330 | 2,314 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $531,973 | 853 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $713,879 | 1,462 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||